Skip to main content

Table 1 Characteristics of study population grouped by cfPWV ≤12 or >12 m/s at follow-up

From: Roles of fasting and postprandial blood glucose in the effect of type 2 diabetes on central arterial stiffness: a 5-year prospective community-based analysis

Characteristics Total (n = 898) CfPWV >12 m/s (n = 707) CfPWV ≤ 12 m/s (n = 191) p valuea p valueb
Age (years) 53 (48–61) 52 (46–59) 63 (54–71) <0.001 <0.001
Age ≥60 (%) 285 (31.7) 168 (23.8) 117 (61.3) <0.001 <0.001
Males (%) 401 (44.7) 302 (42.7) 99 (51.8) 0.025 0.563
Smoker (%) 210 (23.4) 161 (22.8) 49 (25.7) 0.404 0.188
Drinker (%) 190 (21.2) 155 (21.9) 35 (18.3) 0.280 0.001
BMI (kg/m2) 25.23 (23.42–27.55) 25.24 (23.44–27.40) 25.14 (23.18–27.73) 0.782 0.363
Obesity (%) 186 (20.7) 143 (20.2) 43 (22.5) 0.489 0.521
CAD (%) 77 (8.6) 45 (6.4) 32 (16.8) <0.001 0.010
SBP (mmHg) 123 (112–136) 122 (111–132) 131 (120–145) <0.001 0.350
DBP (mmHg) 77 (70–83) 77 (70–83) 79 (70–86) 0.217 0.039
Hypertension (%) 323 (36.0) 213 (30.1) 110 (57.6) <0.001 0.019
TG (mmol/L) 1.42 (1.02–2.08) 1.40 (1.01–2.01) 1.47 (1.06–2.31) 0.096 0.460
High TG (%) 194 (21.6) 144 (20.4) 50 (26.2) 0.083 0.017
HDL-c (mmol/L) 1.37 (1.15–1.61) 1.37 (1.16–1.61) 1.37 (1.13–1.62) 0.791 0.998
Low HDL-c (%) 124 (13.8) 95 (13.4) 29 (15.2) 0.535 0.650
LDL-c (mmol/L) 2.85 (2.39–3.23) 2.84 (2.39–3.21) 2.91 (2.44–3.33) 0.227 0.821
High LDL-c (%) 38 (4.2) 28 (4.0) 10 (5.2) 0.437 0.939
FBG (mmol/L) 4.96 (4.60–5.39) 4.92 (4.59–5.31) 5.11 (4.64–5.65) 0.001 0.014
PBG (mmol/L) 6.09 (5.12–7.70) 5.93 (5.06–7.29) 6.82 (5.52–8.54) <0.001 0.008
T2D (%) 102 (11.4) 66 (9.3) 36 (18.8) <0.001 0.008
Anti-hypertensive drugs (%) 182 (20.3) 114 (16.1) 68 (35.6) <0.001 0.007
Anti-dyslipidemic drugs (%) 40 (4.5) 31 (4.4) 9 (4.7) 0.846 0.953
Anti-diabetic drugs (%) 19 (2.1) 13 (1.8) 6 (3.1) 0.408 0.773
  1. cfPWV carotid femoral pulse wave velocity, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TG: triglyceride, HDL-c high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, FBG fasting blood glucose, PBG postprandial blood glucose, T2D type 2 diabetes
  2. aSimple comparison between groups determined by cfPWV ≤12 or >12 m/s at follow-up
  3. bBivariate correlations of all variables with change of cfPWV